PHARMACOKINETICS OF RECTALLY ADMINISTERED COBITOLIMOD IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: A PHASE IB OPEN-LABEL STUDY

Knittel Thomas  ¹     Pernilla Sandwall  ¹     Christine Dieterich Johansson  ¹     Arezou Zargari  ¹     Johan Bring  ^{1, 2}     Per Martin Hellström  ^3    
1 InDex Pharmaceuticals, Stockholm, Sweden
² Statisticon AB, Uppsala, Sweden
³ Uppsala University, Uppsala, Sweden

Topic
IBD

Session
Medical therapy of IBD: Facts and challenges (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)